FDA inspection
Jiangsu AssurePharma Biotechnology Co., Ltd.: FDA inspection ending Jun 6, 2025
FDA inspection 1274806 · Voluntary Action Indicated (VAI) · Suzhou
Key facts
| Inspection ID | 1274806 |
|---|---|
| Firm | Jiangsu AssurePharma Biotechnology Co., Ltd. |
| FEI number | 3022190679 |
| Address | East Side Of B1-1f/B1-2f, No. 259 Changyang Street; Suzhou Industrial Park |
| City | Suzhou |
| Fiscal year | 2025 |
| Inspection end date | Jun 6, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data